Jilin Huisheng Biopharmaceutical Co,.Ltd.
惠升生物
Jilin Huisheng Biopharmaceutical Co,.Ltd.
Biotech/Healthcare
Huisheng Biopharmaceutical is a provider of treatments for diabetes and its complications. The company is developing comprehensive, end-to-end treatment solutions for patients and has a complete product pipeline covering diabetes and related complications.
Latest round: Series A Extension (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.